Detalhe da pesquisa
1.
Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity.
J Immunol
; 213(1): 7-13, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775415
2.
The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy.
J Biol Chem
; 300(5): 107241, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38556085
3.
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.
Proc Natl Acad Sci U S A
; 119(11): e2112008119, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263223
4.
Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity.
J Biol Chem
; 299(4): 103035, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806685
5.
Epitope Mapping of Therapeutic Antibodies Targeting Human LAG3.
J Immunol
; 209(8): 1586-1594, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104110
6.
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.
Proc Natl Acad Sci U S A
; 118(3)2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431677
7.
T cell receptors employ diverse strategies to target a p53 cancer neoantigen.
J Biol Chem
; 298(3): 101684, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124005
8.
Identification of Endoplasmic Reticulum α-Glucosidase I from a Thermophilic Fungus as a Platform for Structure-Guided Antiviral Drug Design.
Biochemistry
; 61(10): 822-832, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476408
9.
The structural basis of T-cell receptor (TCR) activation: An enduring enigma.
J Biol Chem
; 295(4): 914-925, 2020 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848223
10.
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization.
J Virol
; 94(22)2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878891
11.
In Vivo and In Vitro Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly.
Mol Pharm
; 18(2): 726-734, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32530637
12.
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells.
J Virol
; 93(7)2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651366
13.
Peptide-MHC (pMHC) binding to a human antiviral T cell receptor induces long-range allosteric communication between pMHC- and CD3-binding sites.
J Biol Chem
; 293(41): 15991-16005, 2018 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30135211
14.
Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.
Proc Natl Acad Sci U S A
; 113(45): E6946-E6954, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27791171
15.
Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
J Biol Chem
; 292(45): 18618-18627, 2017 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28931605
16.
The multiple mechanisms of T cell receptor cross-reactivity.
Immunity
; 31(6): 849-51, 2009 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20064442
17.
Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition.
Immunity
; 31(1): 35-46, 2009 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19604491
18.
Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis.
Immunity
; 31(4): 598-608, 2009 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19818651
19.
Kinetic and thermodynamic studies of the interaction between activating and inhibitory Ly49 natural killer receptors and MHC class I molecules.
Biochem J
; 474(1): 179-194, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27831490
20.
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in mice.
Hepatology
; 64(6): 1922-1933, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641232